References
- Alsolamy S, Arabi YM. 2015. Infection with Middle East respiratory syndrome coronavirus. Can. J. Respir. Ther. 51:102.
- Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, et al. 2013. Reverse genetics with a fulllength infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 110: 16157-16162. https://doi.org/10.1073/pnas.1311542110
- Wang C, Zheng X, Gai W, Zhao Y, Wang H, Wang H, et al. 2017. MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques. Oncotarget 8: 12686-12694. https://doi.org/10.18632/oncotarget.8475
- Zhao G, He L, Sun S, Qiu H, Tai W, Chen J, et al. 2018. A novel nanobody targeting middle east respiratory syndrome coronavirus (MERS-CoV) receptor-binding domain has potent cross-neutralizing activity and protective efficacy against MERS-CoV. J. Virol. 92.
- Lee K, Ko HL, Lee E-Y, Park H-J, Kim YS, Kim Y-S, et al. 2018. Development of a diagnostic system for detection of specific antibodies and antigens against Middle East respiratory syndrome coronavirus. Microbiol. Immunol. 62:574-584. https://doi.org/10.1111/1348-0421.12643
- Kim S, Kim S. 2018. Exploring the determinants of perceived risk of Middle East respiratory syndrome (MERS) in Korea. Int. J. Environ. Res. Public Health 15(6).
- Shubin Z, Li W, Poonia B, Ferrari G, LaBranche C, Montefiori D, et al. 2017. An HIV envelope gp120-Fc fusion protein elicits effector antibody responses in rhesus macaques. Clin. Vaccine Immunol. 24.
- Zhao B, Zhang X, Krummenacher C, Song S, Gao L, Zhang H, et al. 2018. Immunization with Fc-based recombinant epstein-barr virus gp350 elicits potent neutralizing humoral immune response in a BALB/c mice model. Front. Immunol. 9.
- Zhang Y, Zhou Z, Zhu SL, Zu X, Wang Z, Zhang LK, et al. 2019. A novel RSV F-Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection. Antiviral Res. 165: 11-22. https://doi.org/10.1016/j.antiviral.2019.02.017
- Kuo TT, Aveson VG. 2011. Neonatal Fc receptor and IgGbased therapeutics. MAbs 3: 422-430. https://doi.org/10.4161/mabs.3.5.16983
- Zhao G, Du L, Ma C, Li Y, Li L, Poon VKM, et al. 2013. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol. J. 10.
- Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, et al. 2017. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl. Acad. Sci. USA 114: E7348-E7357. https://doi.org/10.1073/pnas.1707304114
- Kebriaei A, Derakhshan M, Meshkat Z, Eidgahi MRA, Rezaee SA, Farsiani H, et al. 2016. Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis. Mol. Biol. Rep. 43: 911-922. https://doi.org/10.1007/s11033-016-4024-9
- Jung SY, Kang KW, Lee EY, Seo DW, Kim HL, Kim H, et al. 2018. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine 36: 3468-3476. https://doi.org/10.1016/j.vaccine.2018.04.082
- Trivedi S, Miao C, Al-Abdallat MM, Haddadin A, Alqasrawi S, Iblan I, et al. 2018. Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection. J. Med. Virol. 90: 367-371. https://doi.org/10.1002/jmv.24948
Cited by
- Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity vol.38, pp.18, 2019, https://doi.org/10.1016/j.vaccine.2020.02.089
- Functional Trimeric SARS-CoV-2 Envelope Protein Expressed in Stable CHO Cells vol.9, 2019, https://doi.org/10.3389/fbioe.2021.779359
- Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells vol.326, 2021, https://doi.org/10.1016/j.jbiotec.2020.12.005
- Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants vol.12, pp.5, 2019, https://doi.org/10.1128/mbio.01813-21
- Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2 vol.6, pp.1, 2019, https://doi.org/10.1038/s41541-021-00303-w
- Enhancement of bioactivity, thermal stability and tumor retention by self-fused concatenation of green fluorescent protein vol.28, 2021, https://doi.org/10.1016/j.bbrep.2021.101112
- Development of a recombinant vaccine containing a spike S1-Fc fusion protein induced protection against MERS-CoV in human DPP4 knockin transgenic mice vol.299, 2022, https://doi.org/10.1016/j.jviromet.2021.114347